![Christian Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Hansen
Geen lopende functies
Profiel
Christian Hansen is co-founder and partner of Nordic Biotech.
Dr. Hansen has a background as a biotech entrepreneur, biotech intellectual property rights expert and business development executive, combined with a scientific career.
He has been actively involved in biotech investment since the late 1990’s.
From 2000 to 2001 Dr. Hansen was President of Maxygen's Protein Pharma Division, and Managing Director of its Danish subsidiary Maxygen ApS, employing about 75 people.
From 1999 to 2000, Dr. Hansen was CEO and founder of ProFound Pharma A/S, a Danish start-up company focused on developing 2nd generation protein pharmaceuticals.
From 1992 to 1999, Dr. Hansen held executive positions at Novo Nordisk A/S, including as Director of Intellectual Property Strategy, which is one of his core areas of expertise.
In this capacity, Dr. Hansen was responsible for numerous patent, license and collaborative agreement strategies and negotiations, and was a member of Research Management.
Dr. Hansen holds an MSc (1989) in chemical engineering, a PhD (1992) in molecular biology/biochemistry and an MBA.
Eerdere bekende functies van Christian Hansen
| Bedrijven | Functie | Einde |
|---|---|---|
Blue Note Pharmaceuticals BV
 Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research services | Directeur/Bestuurslid | 04-02-2014 |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Private Equity Investor | 31-12-2013 |
Rose Pharma A/S
 Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome | Directeur/Bestuurslid | 27-06-2012 |
Aditech Pharma AB
 Aditech Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | President | 13-04-2010 |
| OSTEOLOGIX HOLDINGS PLC | Directeur/Bestuurslid | 29-12-2009 |
Opleiding van Christian Hansen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
81
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Osteologix, Inc. /Old/
 Osteologix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Profound Pharma AS
 Profound Pharma AS Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
Rose Pharma A/S
Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome | Health Technology |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Operates as an investment holding company with interest in development of pharmaceuticals | Health Technology |
University of Strasbourg
 University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Blue Note Pharmaceuticals BV
Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research services | Health Technology |
Aditech Pharma AB
Aditech Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
